Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial

Glycosaminoglycans or sulodexide has shown benefits in early experimental diabetic nephropathy (DN) models, but its efficacy in patients with early stage of DN is unknown. Methods. Twenty patients were randomly assigned to the placebo group and another 20 patients were randomly assigned to receive s...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Diabetes Res
Main Authors: Satirapoj, Bancha, Kaewput, Wisit, Supasyndh, Ouppatham, Ruangkanchanasetr, Prajej
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2015
נושאים:
Clinical Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396730/
https://ncbi.nlm.nih.gov/pubmed/25918727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/172038
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים